|  |  | 
		  
              |   |  
              | 
                
                  | 
                      
                        
                          | 【主    题】 : | 4-Thiazolidinone, 5-[[3-chloro-4-[(2R)-2,3-dihydroxypropoxy]phenyl]methylene]-3- |  
                          | 【联系人名】 : | Linna Green |  
                          | 【电子邮件】 : | account@bocsci.com |  
                          | 【联系电话】 : | 15166698109 |  
                          | 【发布日期】 : | 2016-9-6 |  
                          | 【详细说明】 : | "4-Thiazolidinone, 5-[[3-chloro-4-[(2R)-2,3-
dihydroxypropoxy]phenyl]methylene]-3-(2-
methylphenyl)-2-(propylimino)-, (2Z,5Z)-, also 
called Ponesimod, ACT-128800, is a potent, and 
orally active selective S1P(1) agonist with 
potential immunomodulating activity.
In vivio: upon oral administration, ponesimod 
selectively binds to S1PR1 on lymphocytes and causes 
transient receptor activation followed by S1PR1 
internalization and degradation. "
http://www.bocsci.com/4-thiazolidinone-5-3-chloro-4-
2r-2-3-dihydroxypropoxy-phenyl-cas-854107-55-4-item-
459885.html |  
                          |  |  |  |  |